Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant-Methionyl Human Stem Cell Factor (SCF)

recombinant-methionyl human stem cell factor · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant-Methionyl Human Stem Cell Factor (SCF), covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders [Phase 1]

See pricing